FDA Issues Draft Guidance on NASH Drug Development

FDA Issues Draft Guidance on NASH Drug Development

Source: 
RAPS.org
News Tags: 
snippet: 
The US Food and Drug Administration (FDA) on Monday issued draft guidance on developing drugs to treat patients who have noncirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.